Director’s message, Issue 82 After months of wintry grey skies, the sun came. And the coronavirus. Suddenly, we find ourselves in the middle of a crisis.
Reflecting on the lessons of a past pandemic – A career comes full circle At the end of an eventful career, UMC’s retiring chief medical officer, reflects on how the lessons of the H1N1 pandemic helped prepare the pharmacovigilance world for COVID-19.
Ruminations on the future of pharmacovigilance – new podcast out now After the pandemic: what were the lessons learnt for pharmacovigilance? Find out in the latest episode of the Drug Safety Matters podcast.
Into the infodemic: Countering COVID's medicine myths As the COVID-19 pandemic spread around the world, so did wave of viral misinformation. For pharmacovigilance, fighting the “infodemic” is a massive, but necessary, battle.
New film goes behind the scenes of UMC’s pandemic operations A new short film captures UMC's work to support the pharmacovigilance community as it prepares to take on COVID-19. Filmmaker Matthew Barwick explains the thinking behind it.
New podcast episode – Into the infodemic Tune in to the latest in our Drug Safety Matters Long Reads series, exploring how pharmacovigilance experts can help win the war on viral misinformation – by not fighting it.
Pharmacovigilance in the age of COVID-19 COVID-19 is one of the most disruptive events in history and a threat to public health. In the rush for treatments and vaccines, how do we keep sight of the need to ensure safety?
Substandard and Falsified COVID-19 Vaccines in the Americas: Can vaccine equity help? COVID-19 vaccinations are picking up speed in wealthy countries. But for lower-income countries, does poor equity of access raise the risk of compromised products?
